(27 days)
Not Found
No
The device description details a purely mechanical system for controlled fluid delivery based on spring pressure and flow restrictor dimensions. There is no mention of software, algorithms, or data processing that would indicate the use of AI or ML.
Yes
The device is intended for the infusion of medications or fluids and continuous infusion of local anesthetic for postoperative pain management, aligning with the definition of a therapeutic device designed to treat or alleviate a condition.
No
The device is described as an infusion system for delivering medications and fluids, not for diagnosing conditions.
No
The device description clearly outlines physical components such as a spring-pressurized reservoir, syringe-like medication reservoir, piston, administration set, flow restrictor, and procedure kit components, indicating it is a hardware device.
Based on the provided information, the Beeline system is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use clearly describes the device as being used for the infusion of medications or fluids directly into the body (intravenous, intra-arterial, enteral, subcutaneous, epidural, and intraoperative sites). This is a therapeutic or drug delivery function.
- Device Description: The description details a mechanical system for delivering fluids under pressure. It does not mention any components or processes related to testing samples in vitro (outside the body) to diagnose or monitor a medical condition.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting analytes, or providing diagnostic information.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for diagnosis, monitoring, or screening. The Beeline system's function is to deliver substances into the body, which is a different category of medical device.
N/A
Intended Use / Indications for Use
The Beeline system is indicated for intravenous, intra-arterial, enteral, subcutaneous and epidural infusion of medications or fluids requiring continuous delivery at controlled infusion rates.
The Beeline system is also intended to provide continuous infusion of a local anesthetic directly into the intraoperative site for postoperative pain management.
Product codes (comma separated list FDA assigned to the subject device)
FRN
Device Description
The Beeline device consists of a spring-pressurized, syringe-like medication reservoir with a flowrate-controlling administration set. Medication is held between the barrel and piston of the infuser. A spring applies force against the piston, pressurizing the medication. The administration set includes a flow restrictor component with controlled internal diameter and length. The flow rate at which medication is dispensed from the system is a function of the pressure applied to the medication and the dimensions of the flow restrictor component.
The size of the reservoir and the amount of flow restriction are varied during manufacturing to yield a variety of product codes with differing infusion volumes and flowrates.
A procedure kit provides various components that facilitate setup and use of the Beeline system. Examples of kit components include items such as a prep tray, sterile drape, transfer syringe, medication/chart labels, catheter & introducer, dressing, tape, gauze, prep pads/wipes, carrying case, etc. Multiple kit product codes are made, with the contents varied as applicable for the particular procedure.
The Beeline system is intended for single patient use.
The Beeline system has fill volumes and flow rates substantially equivalent to the named predicate devices. The nominal fill volume of the system is 100 mL (small infuser) or 275 mL (large infuser). The nominal flow rate ranges from 0.4 to 10 mL/hr. Flow rate accuracy is ±15% of nominal flow rate, for all product codes. Residual volume is 5 mL or less.
Operating pressure averages approximately 6 psi.
As with the identified predicate devices, fluid viscosity, temperature, and head height affect flow rate.
The device is calibrated to deliver at the nominal flow rate using D5W (5% dextrose in water) as the infusate. Changing from D5W to sterile water increases flow rate by approximately 10%.
The device is calibrated to deliver at the nominal flow rate at skin temperature (86 °F). Flow rate changes by approximately 1% per °F.
The device is calibrated to deliver at the nominal flow rate with the medication reservoir 18" below the infusion site. Raising the infuser will increase the flow rate by less than 1% per inch.
The fluid path materials are chosen from those commonly used in infusion devices. Examples of the types of material used include polypropylene; polyethylene; PVC; acrylic; polycarbonate; ABS; silicone, butyl, nitrile, or other latex-free rubber; polyimide; nylon; PTFE; cellulose acetate; glass; stainless steel. The actual materials used vary slightly, depending on the product code (e.g., different procedure kit components may use different materials).
The Beeline system and the identified predicate devices control the flow rate with a length of micro-bore tubing made from glass, PVC, polyethylene or similar appropriate material. All fluid path materials of the Beeline system are in conformance with ISO 10993-1 biocompatibility standards.
There are currently no approved performance standards established for spring pumps under Section 514 of the Food, Drug and Cosmetic Act.
Packaging is suitable for both EtO and gamma radiation sterilization. For product codes sterilized with EtO, the EtO cycle is validated per ISO 11135 and residuals are validated per ISO 10993-7. For product codes sterilized with gamma radiation, the sterilization dose is validated per ISO 11137.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Intravenous, intra-arterial, enteral, subcutaneous and epidural (for infusion)
Intraoperative site (for local anesthetic)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5725 Infusion pump.
(a)
Identification. An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows two black shapes that appear to be separated by a white space. The shape on the left is a triangle, while the shape on the right is a quadrilateral. The shapes are simple and abstract, and the image is black and white. The shapes are positioned next to each other, but they do not touch.
McKinley
SEP 2 3 2003
McKinley Medical LLLP 4080 Youngfield Street Wheat Ridge, CO 80033 USA 303.420.9569 303.420.8585 Fax
510(k) Summary—Special 510(k) for Modifications to the McKinley Beeline System
| Date Prepared: | 15 August 2003 |
|---|---|
| Submitter: | McKinley Medical, LLLP |
| 4080 Youngfield Street | |
| Wheat Ridge, CO 80033 | |
| Phone: 303-420-9569 | |
| Fax: 303-420-8585 | |
| Contact for questions: Andy Lamborne | |
| Trade Name: | Beeline Motiv |
| Common Name: | Spring Pump & Kit |
| Classification Name: | Infusion Pump |
| Classification Panel: | General Hospital and Personal Use Device |
| Regulation Number: | Class II, 880.5725 |
| Panel: | 80 |
| Procode: | FRN – Infusion Pump |
| Original cleared 510(k): | K990461 |
| Establishment Registration: | 1723533 |
| Owner/Operator Number: | 9027257 |
Summary of Safety and Effectiveness of the Beeline System 5.
- This submission is intended to notify the Food and Drug Administration that 5.1 McKinley Medical, LLLP intends to market a modification to an existing device (K990461) called the Beeline system. Modifications to the existing device are extension of the flow rate range, addition of a larger reservoir volume, and addition of procedure kits.
- The original cleared device demonstrating substantial equivalence is the 5.2 McKinley Spring Pump Disposable Infusion Pump (K990461).
1
- A supporting predicate device also demonstrating substantial equivalence is 5.3 McKinley's Accufuser, Accufuser Plus & standard procedure kit (K023098).
- 5.4 The cleared indications for use for the Beeline system are as follows:
The Beeline system is indicated for intravenous, intra-arterial, enteral, subcutaneous and epidural infusion of medications or fluids requiring continuous delivery at controlled infusion rates.
The Beeline system is also intended to provide continuous infusion of a local anesthetic directly into the intraoperative site for postoperative pain management.
- Summary Description of the Beeline system 5.5
- 5.5.1 The Beeline device consists of a spring-pressurized, syringe-like medication reservoir with a flowrate-controlling administration set. Medication is held between the barrel and piston of the infuser. A spring applies force against the piston, pressurizing the medication. The administration set includes a flow restrictor component with controlled internal diameter and length. The flow rate at which medication is dispensed from the system is a function of the pressure applied to the medication and the dimensions of the flow restrictor component.
- 5.5.2 The size of the reservoir and the amount of flow restriction are varied during manufacturing to yield a variety of product codes with differing infusion volumes and flowrates.
- A procedure kit provides various components that facilitate setup 5.5.3 and use of the Beeline system. Examples of kit components include items such as a prep tray, sterile drape, transfer syringe, medication/chart labels, catheter & introducer, dressing, tape, gauze, prep pads/wipes, carrying case, etc. Multiple kit product codes are made, with the contents varied as applicable for the particular procedure.
- 5.5.4 The Beeline system is intended for single patient use.
- 5.5.5 Device Specifications
- The Beeline system has fill volumes and flow rates a. substantially equivalent to the named predicate devices.
- . The nominal fill volume of the system is 100 mL (small infuser) or 275 mL (large infuser).
- The nominal flow rate ranges from 0.4 to 10 mL/hr. ●
- Flow rate accuracy is ±15% of nominal flow rate, for all . product codes.
- . Residual volume is 5 mL or less.
- b. Operating pressure averages approximately 6 psi.
- As with the identified predicate devices, fluid viscosity, c. temperature, and head height affect flow rate.
- The Beeline system has fill volumes and flow rates a. substantially equivalent to the named predicate devices.
2
- The device is calibrated to deliver at the nominal flow rate . using D5W (5% dextrose in water) as the infusate. Changing from D5W to sterile water increases flow rate by approximately 10%.
- . The device is calibrated to deliver at the nominal flow rate at skin temperature (86 °F). Flow rate changes by approximately 1% per °F.
- The device is calibrated to deliver at the nominal flow rate . with the medication reservoir 18" below the infusion site. Raising the infuser will increase the flow rate by less than 1% per inch.
- d. The fluid path materials are chosen from those commonly used in infusion devices.
- . Examples of the types of material used include polypropylene; polyethylene; PVC; acrylic; polycarbonate; ABS; silicone, butyl, nitrile, or other latex-free rubber; polyimide; nylon; PTFE; cellulose acetate; glass; stainless steel. The actual materials used vary slightly, depending on the product code (e.g., different procedure kit components may use different materials).
- . The Beeline system and the identified predicate devices control the flow rate with a length of micro-bore tubing made from glass, PVC, polyethylene or similar appropriate material.
- . All fluid path materials of the Beeline system are in conformance with ISO 10993-1 biocompatibility standards.
- e. There are currently no approved performance standards established for spring pumps under Section 514 of the Food, Drug and Cosmetic Act.
- f. Packaging is suitable for both EtO and gamma radiation sterilization.
- . For product codes sterilized with EtO, the EtO cycle is validated per ISO 11135 and residuals are validated per ISO 10993-7.
- For product codes sterilized with gamma radiation, the . sterilization dose is validated per ISO 11137.
- 5.5.6
- Device Safety Functions
- The Beeline system provides a fixed flow determined by the a. applied force from the compressed spring and the flow restriction induced by the dimensions of the flow restrictor. The Beeline system is not subject to infusion runaway conditions as may occur with some electronic pumps.
3
- b. The administration set includes a clamp, allowing the user to stop flow if necessary.
- The administration set has a 1.2-micron or smaller airc. eliminating filter.
- d. The fluid path is clear or translucent, allowing visual inspection of the contents.
- e. The medication reservoir has syringe-like graduation marks to provide an approximate indication of remaining volume, allowing the user to monitor the infusion progress.
- Conclusion: The modified Beeline system does not raise any new safety and 5.6 efficacy concerns when compared to the original device that is already legally marketed. The Beeline system is substantially equivalent to the named predicate devices.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, representing the department's mission to protect the health of all Americans and provide essential human services.
Public Health Service
SEP 2 3 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Andrew N. Lamborne Director of Engineering McKinley Medical, LLLP 4080 Youngfield Street Wheat Ridge, Colorado 80033
Re: K032642
Trade/Device Name: Beeline Motiv Spring Pump & Kit Regulation Number: 880.5725 Regulation Name: Infusion Pump Regulatory Class: II Product Code: FRN Dated: August 15, 2003 Received: August 27, 2003
Dear Mr. Lamborne:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2 -Mr. Lamborne
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4618. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Susan Bunne
Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use Statement 3.
Page 1 of 1
Applicant: McKinley Medical, LLLP
1-032642 510(k) Number (if known):____
Device Name: Beeline System
Indications for Use:
The Beeline system is indicated for intravenous, intra-arterial, enteral, subcutaneous and epidural infusion of medications or fluids requiring continuous delivery at controlled infusion rates.
The Beeline system is also intended to provide continuous infusion of a local anesthetic directly into the intraoperative site for postoperative pain management.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Peltaro Cucente
(Division Signa)
Inesthesiology, General Hospital,
510(k) Number: Y032642
(Optional Format 3-10-98)